Handbook of Clinical medicine

marker or organic disease (T°, blood PR, weight): colonoscopy. • Have a low threshold for referring if family history of ovarian or bowel cancer. • : excluding ovarian cancer requires serum CA-125 (OHCS p281); endo m etriosis (OHCS p288) often mimics IBS: consider if pain cyclical. • If IBS criteria not met, consider clinical context and decide upon: stool culture; B12/folate; TSH; faecal calprotectin (p262). Refer if: 1 Diagnostic uncertainty (you or the patient!). 2 If changing symptoms in ‘known IBS’. 3 Refractory to management: stress or depression (seen in ≥50%) or refractory symptoms (here, NICE favours cognitive therapy, OHCS p390), chronic pain overlap syndromes (fi bromyalgia + chronic fatigue + chronic pelvic pain) or detrusor problems. Treatment: Should focus on controlling symptoms, initially using lifestyle/dietary measures, then cognitive therapy (OHCS p390) or pharmacotherapy if required: • Constipation: ensure adequate water and fi bre intake and promote physical activity; (fi bre intake can worsen fl atule nce/bloating so avoid insoluble fi bre, such as bran; oats are better). Simple laxatives (p260, but beware lactulose which ferments and can aggravate bloating). If 2 of these fail, try prucalopride, linaclotide, or lubiprostone; or self-administered anal irrigation. • Diarrhoea: avoid sorbitol sweeteners, alcohol,
